Targeting IKKα kinase to prevent tumor progression and therapy resistance

Abstract

Cancer therapy has improved considerably in the last years; however, therapeutic resistance is still a major problem that impedes full response to the treatment and the main cause of patient relapse and death. Numerous kinases have been reported to be overactivated in cancer and induce resistance to current therapies. Targeting kinases has proven to be useful for overcoming chemotherapy resistance and thus improving patient outcomes. Inhibitor of kappaB kinase alpha (IKKα) is a serine/threonine kinase that was first described as part of the IKK complex in the nuclear factor-κB (NF-κB) pathway, which regulates several physiological and physiopathological processes such as immunity, inflammation, and cancer. However, the IKKα subunit has been shown to be dispensable for NF-κB activation and responsible of multiple pro-tumorigenic functions. Furthermore, we identified a nuclear active form of IKKα kinase IKKα(p45) that promotes tumor growth and therapy resistance, independent of canonical NF-κB. Improved understanding of resistance mechanisms will facilitate drug discovery and provide new effective therapies. Here, we review the recent publications on the implications of IKKα in cancer initiation, development, and resistance.

Keywords

IKKα / cancer / therapeutic targets / chemoresistance

References

[1] Global Burden of Disease Collaborative Network. Global Burden of Disease Study 2016 (GBD 2016) Results [Institute for Health Metrics and Evaluation (IHME), 2017]. Available from https://www.who.int/news-room/fact-sheets/detail/cancer [Last accessed on 20 Mar 2020]

[2] Kannaiyan R.A comprehensive review of protein kinase inhibitors for cancer therapy..Expert Rev Anticancer Ther2018;18:1249-70 PMCID:PMC6322661

[3] Roskoski R Jr.Properties of FDA-approved small molecule protein kinase inhibitors: a 2020 update..Pharmacol Res2020;152:104609

[4] Colomer C,Villanueva A,Pecharroman I.IKKα kinase regulates the DNA damage response and drives chemo-resistance in cancer..Mol Cell2019;75:669-82.e5 PMCID:PMC6715775

[5] Roseweir AK,Dickson A,Quintayo MA.Predictive biomarkers for endocrine therapy: retrospective study in tamoxifen and exemestane adjuvant multinational (TEAM) trial..J Natl Cancer Inst2018;110:616-27

[6] Colomer C,Vert A,Espinosa L.NF-κB members left home: NF-κB-independent roles in cancer..Biomedicines2017;5:26 PMCID:PMC5489812

[7] Régnier CH,Gao X,Cao Z.Identification and characterization of an IκB kinase..Cell1997;90:373-83

[8] Zandi E,Delhase M,Karin M.The IkappaB kinase complex (IKK) contains two kinase subunits, IKKalpha and IKKbeta, necessary for IkappaB phosphorylation and NF-kappaB activation..Cell1997;91:243-52

[9] Häcker H.Regulation and function of IKK and IKK-related kinases..Sci STKE2006;2006:re13

[10] Mercurio F.IKK-1 and IKK-2: cytokine-activated IκB kinases essential for NF-B activation..Science1997;278:860-6 PMCID:PMC2829958

[11] Hinz M.The IκB kinase complex in NF-κB regulation and beyond..EMBO Rep2014;15:46-61 PMCID:PMC4303448

[12] Gilmore TD.Inhibitors of NF-κB signaling: 785 and counting..Oncogene2006;25:6887-99

[13] Gilmore TD.Inhibition of NF-κB signaling as a strategy in disease therapy..Curr Top Microbiol Immunol2011;349:245-63

[14] Karin M,Wang QM.The IKK NF-kappa B system: a treasure trove for drug development..Nat Rev Drug Discov2004;3:17-26

[15] Prescott J.Targeting IKKβ in cancer: challenges and opportunities for the therapeutic utilisation of IKKβ inhibitors..Cells2018;7:115 PMCID:PMC6162708

[16] Chariot A.The NF-kappaB-independent functions of IKK subunits in immunity and cancer..Trends Cell Biol2009;19:404-13

[17] Margalef P,Villanueva A,Iglesias M.A truncated form of IKKα is responsible for specific nuclear IKK activity in colorectal cancer..Cell Rep2012;2:840-54

[18] Zhu F,Liu B,Hu Y.IKKalpha shields 14-3-3sigma, a G(2)/M cell cycle checkpoint gene, from hypermethylation, preventing its silencing..Mol Cell2007;27:214-27

[19] Fernández-Majada V,Villanueva A,Robert-Moreno A.Nuclear IKK activity leads to dysregulated notch-dependent gene expression in colorectal cancer..Proc Natl Acad Sci U S A2007;104:276-81 PMCID:PMC1765449

[20] Fernández-Majada V,Vilardell F,Mayo MW.Aberrant cytoplasmic localization of N-CoR in colorectal tumors..Cell Cycle2007;6:1748-52

[21] Anest V,Cogswell PC,Strahl BD.A nucleosomal function for IκB kinase-α in NF-κB-dependent gene expression..Nature2003;423:659-63

[22] Hoberg JE,Mayo MW.SMRT derepression by the IkappaB kinase alpha: a prerequisite to NF-kappaB transcription and survival..Mol Cell2004;16:245-55

[23] Albanese C,D’Amico M,Joyce D.IKKalpha regulates mitogenic signaling through transcriptional induction of cyclin D1 via Tcf..Mol Biol Cell2003;14:585-99 PMCID:PMC149994

[24] Marinari B,Botti E,Descargues P.The tumor suppressor activity of IKKalpha in stratified epithelia is exerted in part via the TGF-beta antiproliferative pathway..Proc Natl Acad Sci U S A2008;105:17091-6 PMCID:PMC2579383

[25] Descargues P,Sano Y,Han G.IKKalpha is a critical coregulator of a Smad4-independent TGFbeta-Smad2/3 signaling pathway that controls keratinocyte differentiation..Proc Natl Acad Sci U S A2008;105:2487-92 PMCID:PMC2268163

[26] Alameda JP,Ramírez Á,Page A.Deciphering the role of nuclear and cytoplasmic IKKα in skin cancer..Oncotarget2016;7:29531-47 PMCID:PMC5045415

[27] Vreka M,Papageorgopoulou M,Lianou M.IkB kinase a is required for development and progression of KRAS-mutant lung adenocarcinoma..Cancer Res2018;78:2939-51 PMCID:PMC6485619

[28] Ducut Sigala JL,Young DB,Mercurio F.Activation of transcription factor NF-κB requires ELKS, an IkappaB kinase regulatory subunit..Science2004;304:1963-7

[29] Cao Y,Karin M.IkappaB kinase alpha kinase activity is required for self-renewal of ErbB2/Her2-transformed mammary tumor-initiating cells..Proc Natl Acad Sci U S A2007;104:15852-7 PMCID:PMC2000410

[30] Jia J,Yan B,Lai W.LGR5 expression is controled by IKKα in basal cell carcinoma through activating STAT3 signaling pathway..Oncotarget.2016;7:27280-94 PMCID:PMC5053649

[31] Colomer C,Gonzalez J,Bigas A.IKKα is required in the intestinal epithelial cells for tumour stemness..Br J Cancer2018;118:839-46 PMCID:PMC5877427

[32] Mulero MC,Islam A,Pecoraro M.Chromatin-bound IκBα regulates a subset of polycomb target genes in differentiation and cancer..Cancer Cell2013;24:151-66 PMCID:PMC3962677

[33] Fernández-Majada V,Villanueva A,Robert-Moreno A.Nuclear IKK activity leads to dysregulated Notch-dependent gene expression in colorectal cancer..Proc Natl Acad Sci U S A2007;104:276-81

[34] Margalef P,Villanueva A,Iglesias M.BRAF-induced tumorigenesis is IKKα-dependent but NF-κB-independent..Sci Signal2015;8:ra38

[35] Luo JL,Ricono JM,Zhang M.Nuclear cytokine-activated IKKα controls prostate cancer metastasis by repressing Maspin..Nature2007;446:690-4

[36] Ammirante M,Grivennikov S,Karin M.B-cell-derived lymphotoxin promotes castration-resistant prostate cancer..Nature2010;464:302-5 PMCID:PMC2866639

[37] Toll A,Masferrer E,Gimeno J.Active nuclear IKK correlates with metastatic risk in cutaneous squamous cell carcinoma..Arch Dermatol Res2015;307:721-9

[38] Page A,Alameda JP,Paramio JM.IKKα promotes the progression and metastasis of non-small cell lung cancer independently of its subcellular localization..Comput Struct Biotechnol J2019;17:251-62 PMCID:PMC6396199

[39] Gonzalez-Suarez E,Jones J,Roudier-Meyer MP.RANK ligand mediates progestin-induced mammary epithelial proliferation and carcinogenesis..Nature2010;468:103-7

[40] Schramek D,Sigl V,Pospisilik JA.Osteoclast differentiation factor RANKL controls development of progestin-driven mammary cancer..Nature2010;468:98-102 PMCID:PMC3084017

[41] Tan W,Strasner A,Cheng JQ.Tumour-infiltrating regulatory T cells stimulate mammary cancer metastasis through RANKL-RANK signalling..Nature2011;470:548-53 PMCID:PMC3166217

[42] Wu RC,Hashimoto Y,Xu J.Regulation of SRC-3 (pCIP/ACTR/AIB-1/RAC-3/TRAM-1) coactivator activity by I kappa B kinase..Mol Cell Biol2002;22:3549-61 PMCID:PMC133790

[43] Park KJ,O’Malley BW,Gaynor RB.Formation of an IKKα-dependent transcription complex is required for estrogen receptor-mediated gene activation..Mol Cell2005;18:71-82

[44] Bennett L,McCall P,Horgan PG.High IKKα expression is associated with reduced time to recurrence and cancer specific survival in oestrogen receptor (ER)-positive breast cancer..Int J Cancer2017;140:1633-644

[45] Hossain F,Ucar DA,Matossian M.Notch signaling regulates mitochondrial metabolism and NF-κB activity in triple-negative breast cancer cells via IKKα-dependent non-canonical pathways..Front Oncol2018;8:575 PMCID:PMC6289043

[46] Folmer F,Dicato M.Marine natural products as targeted modulators of the transcription factor NF-kappaB..Biochem Pharmacol2008;75:603-17

[47] Ríos JL,Escandell JM.Inhibition of transcription factors by plant-derived compounds and their implications in inflammation and cancer..Curr Pharm Des2009;15:1212-37

[48] Castro AC,Soucy F,Mazdiyasni H.Novel IKK inhibitors: β-carbolines..Bioorg Med Chem Lett2003;13:2419-22

[49] Habineza Ndikuyeze G,Patel R.A phase I clinical trial of systemically delivered NEMO binding domain peptide in dogs with spontaneous activated B-cell like diffuse large B-cell lymphoma..PLoS One2014;9:e95404 PMCID:PMC4010398

[50] Lee DF.Advances in targeting IKK and IKK-related kinases for cancer therapy..Clin Cancer Res2008;14:5656-62 PMCID:PMC2613770

[51] Shukla S,Shankar E,Chance MR.Apigenin blocks IKKα activation and suppresses prostate cancer progression..Oncotarget2015;6:31216-32 PMCID:PMC4741599

[52] Leopizzi M,Milanetti E,Politi L.IKKα inibition by a glucosamine derivative enhances Maspin expression in osteosarcoma cell line..Chem Biol Interact2017;262:19-28

[53] Anthony NG,Berretta G,Breen D.Inhibitory kappa B kinase α (IKKα) inhibitors that recapitulate their selectivity in cells against isoform-related biomarkers..J Med Chem2017;60:7043-66 PMCID:PMC5578373

[54] Lam LT,Pierce J,Xu Y.Small molecule inhibitors of IkappaB kinase are selectively toxic for subgroups of diffuse large B-cell lymphoma defined by gene expression profiling..Clin Cancer Res2005;11:28-40

[55] Schön M,Kneitz S,Amschler K.KINK-1, a novel small-molecule inhibitor of IKKβ, and the susceptibility of melanoma cells to antitumoral treatment..J Natl Cancer Inst2008;100:862-75

[56] Dai L,Liu XY,Cheung PC.TAK1, more than just innate immunity..IUBMB Life2012;64:825-34

[57] Sakurai H,Hasegawa K.TGF-beta-activated kinase 1 stimulates NF-kappa B activation by an NF-kappa B-inducing kinase-independent mechanism..Biochem Biophys Res Commun1998;243:545-9

[58] Yamaguchi K,Shibuya H,Oishi I.Identification of a member of the MAPKKK family as a potential mediator of TGF-β signal transduction..Science1995;270:2008-11